۲-Arachidonoylglycerol enrichment Reduced Epileptiform Activity of the Rat Hippocampus induced with Pentylenetetrazol

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 305

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ZUMS-26-118_004

تاریخ نمایه سازی: 11 اردیبهشت 1400

Abstract:

Background and Objective: ۲-arachidonoylglycerol (۲-AG) and anandamide (AEA) are two major endocannabinoids. Using inhibitors of the enzymatic pathways involved in the elimination of ۲-AG and AEA as well as synthetic ۲-AG, we examined the effectiveness of these endocannabinoids on epileptiform activity induced in Wistar rats by pentylenetetrazol (PTZ). Material and Methods: Adult male Wistar rats were used in this study. Epileptiform activity was induced in dult male Wistar rats by PTZ injection (۲۰ mg/kg, i.p.). To inhibit ۲-AG degradation WWL۷۰ and JJKK۰۴۸ (JJKK۰۴۸: ۱ mg/kg, WWL۷۰: ۵ mg/kg, i.p.) were used. To inhibit AEA elimination, URB۵۹۷ and LY۲۱۸۳۲۴۰ (URB۵۹۷: ۱ mg/kg, LY۲۱۸۳۲۴۰: ۲.۵ mg/kg, i.p.) were used. Synthetic ۲-AG was also examined (۱ mg/kg, i.p.) before the PTZ injection. All drugs were dissolved in DMSO as vehicle and injected (i.p.) ۱۵ minutes before the PTZ injection. Latency to onset and duration of the epileptiform activity were considered for statistical analysis. Results: Injection of (JJKK۰۴۸+WWL۷۰) before the PTZ significantly increased latency to onset of the epileptiform activity (p<۰.۰۱), while reduced duration of the epileptiform activity in comparison to the vehicle (p<۰.۰۵). In addition, ۲-AG administration significantly increased latency to onset of the epileptiform activity (p<۰.۰۵) and reduced duration of the epileptiform activity in comparison to the vehicle (p<۰.۰۱). However, these indexes did not show significant changes when URB۵۹۷+LY۲۱۸۳۲۴۰ were injected before the PTZ (p>۰.۰۵). Conclusion: It seems increased level of ۲-AG but not AEA,effectively decreases PTZ induced epileptiform activity of the hippocampus.

Authors

پریسا زارعی

Dept of Physiology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran

مهدی صادقی

Dept. of Fundamental Neurobiology, Krembil Research Institute, Toronto, Ontario, Canada

حمیرا مرادی چامه

Dept. of Fundamental Neurobiology, Krembil Research Institute, Toronto, Ontario, Canada

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • de Boer HM, Mula M, Sander JW. The global burden ...
  • Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. ...
  • Hill AJ, Williams CM, Whalley BJ, Stephens GJ. Phytocannabinoids as ...
  • Russo EB. Cannabis and epilepsy: An ancient treatment returns to ...
  • dos Santos RG, Hallak JE, Leite JP, Zuardi AW, Crippa ...
  • Ligresti A, Cascio MG, Di Marzo V. Endocannabinoid metabolic pathways ...
  • Battista N, Di Tommaso M, Bari M, Maccarrone M. The ...
  • Savinainen J, Saario S, Laitinen J. The serine hydrolases MAGL, ...
  • Basavarajappa BS. Critical enzymes involved in endocannabinoid metabolism. Protein Pept ...
  • Sugaya Y, Yamazaki M, Uchigashima M, et al. Crucial Roles ...
  • Fezza F, Marrone MC, Avvisati R, et al. Distinct modulation ...
  • Zareie P, Sadegh M, Palizvan M. The effect of 2-archidonyl ...
  • Zareie P, Sadegh M, Palizvan M. Investigating the effect of ...
  • Naydenov AV, Horne EA, Cheah CS, et al. ABHD6 blockade ...
  • Aaltonen N, Savinainen JR, Ribas CR, et al. Piperazine and ...
  • Wen J, Ribeiro R, Tanaka M, Zhang Y. Activation of ...
  • Hasanein P, Ghafari-Vahed M. Fatty acid amide hydrolase inhibitor URB597 ...
  • Maione S, Morera E, Marabese I, et al. Antinociceptive effects ...
  • Wakley AA, Rasmussen EB. Effects of cannabinoid drugs on the ...
  • Depaulis A, Snead OC, Marescaux C, Vergnes M. Suppressive effects ...
  • Snead OC, Banerjee PK, Burnham M, Hampson D. Modulation of ...
  • Schwenk J, Harmel N, Brechet A, et al. High-resolution proteomics ...
  • Ludanyi A, Eross L, Czirjak S, et al. Downregulation of ...
  • Hill TD, Cascio MG, Romano B, et al. Cannabidivarin-rich cannabis ...
  • Griebel G, Pichat P, Beeske S, et al. Selective blockade ...
  • Sigel E, Baur R, Racz I, et al. The major ...
  • Citraro R, Russo E, Scicchitano F, et al. Antiepileptic action ...
  • Deshpande LS, Blair RE, Ziobro JM, Sombati S, Martin BR, ...
  • Clement AB, Hawkins EG, Lichtman AH, Cravatt BF. Increased seizure ...
  • Corvino V, Marchese E, Podda MV, et al. The neurogenic ...
  • Hoover HS, Blankman JL, Niessen S, Cravatt BF. Selectivity of ...
  • Ma L, Wang L, Yang F, et al. Disease‐modifying effects ...
  • Curia G, Longo D, Biagini G, Jones RS, Avoli M. ...
  • Löscher W. Critical review of current animal models of seizures ...
  • Blair RE, Deshpande LS, Sombati S, Elphick MR, Martin BR, ...
  • نمایش کامل مراجع